Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,864
Sort by:
Global Prostate Cancer Therapeutics Market to 2020
US$ 1,000.00
... position, while immunotherapy for prostate cancer stands at the last positon in the prostate cancer therapeutics market. Prostate Cancer Drugs Analysis: Zytiga leads the prostate cancer drugs market in 2014. Zytiga is facing ... “Global Prostate Cancer Therapeutics Market to 2020” is a 76 page report with 43 Figures and 4 Tables. This report analyses the Prostate Cancer Therapy Market, Prostate Cancer Drugs Market, driving factors and challenges for prostate cancer market ...
May 2015
76 pages
Global Melanoma Therapeutics Industry 2015 Market Research Report
US$ 2,850.00
2015 Global Melanoma Therapeutics Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Melanoma Therapeutics industry, focusing on the main ... with: 1.) basic information; 2.) the Asia Melanoma Therapeutics industry; 3.) the North American Melanoma Therapeutics industry; 4.) the European Melanoma Therapeutics industry; 5.) market entry and investment feasibility ...
May 2015
170 pages
Global Breast Cancer Monoclonal Antibodies Market Outlook 2020
US$ 1,800.00
... Cancer Monoclonal Antibodies Pipeline: 62 mAb Majority Breast Cancer Monoclonal Antibodies in Preclinical Phase: 17 mAb Marketed Breast Cancer Monoclonal Antibodies: 6 mAb Marketed Breast Cancer Monoclonal Antibodies Clinical Insight Bevacizumab (Avastin) Pertuzumab (Omnitarg, Perjeta) Trastuzumab (Herceptin ...
May 2015
190 pages
Personalised Medicines in Oncology: Assessing Key Drivers and Challenges at the Physician Level (US)
US$ 6,900.00
... value and benefits of personalised medicine and on the key challenges and opportunities in relation to implementation from treating oncologists. Personalised Medicines in Oncology: Assessing Key Drivers and Challenges ... to development, access and implementation of personalised healthcare strategies. This survey provides US physician insights into personalised medicine within the oncology setting. By understanding what oncologists ...
April 2015
The Future of Cancer Immunotherapy: KOL Views Bring Opportunities into Sharp Focus
US$ 1,950.00
... the best results. The bottom line here is that cancer immunotherapies will revolutionise cancer treatment and the fortunes of the companies who bring ... -Sarcoma Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA Paolo A. Ascierto, MD, Cancer Immunotherapy and Innovative Therapy Unit Istituto Nazionale ...
April 2015
European Pap Smear/HPV Market 2015
US$ 2,280.00
... , sales forecasts) $1,850.This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance ... test volume and sales forecasts by country and market segment. The report examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies ...
April 2015
235 pages
Cancer Targeted Therapy Market & Clinical Insight 2015
US$ 3,300.00
... Cancer Targeted Therapy Market & Clinical Insight” Report Highlight: Introduction & Categorization of Cancer Targeted Therapies Mechanism of Cancer Targeted Tyrosine Kinase, Vaccines, Oncogenes Inhibitors, Monoclonal Antibodies Cancer Targeted Therapy ...
April 2015
2900 pages
Cancer Growth Inhibitors Market & Clinical Pipeline Analysis
US$ 2,400.00
... Cancer Growth Inhibitors Cancer Growth Inhibitors Clinical Pipeline by Company, Indication & Phase Cancer Growth Inhibitors Clinical Pipeline: 629 Drugs Markets Cancer Growth Inhibitors: 48 Drugs Tyrosine Kinase Dominates Cancer Growth Inhibitors Pipeline: 394 Drugs HDAC Inhibitors Clinical Pipeline: 65 Drugs ...
April 2015
1000 pages
US Thyroid Cancer Market: Trends and Opportunities (2015 – 2019)
US$ 800.00
... “US Thyroid Cancer Market: Trends and Opportunities (2015-2019)” provides an insight into the overall thyroid cancer market of the United States of America. The report analyzes in detail the segments of Thyroid Cancer Market that ... titled “US Thyroid Cancer Market: Trends and Opportunities (2015-2019)” provides an insight into overall thyroid cancer sector of United States of America. The report includes detailed information on market size, installed ...
March 2015
75 pages
Global Breast Cancer Imaging Industry 2015 Market Research Report
US$ 2,850.00
2015 Global Breast Cancer Imaging Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Breast Cancer Imaging industry, focusing on the ... with: 1.) basic information; 2.) the Asia Breast Cancer Imaging industry; 3.) the North American Breast Cancer Imaging industry; 4.) the European Breast Cancer Imaging industry; 5.) market entry and investment feasibility ...
March 2015
172 pages
Global In-vitro Colorectal Cancer Screening Tests Industry 2015 Market Research Report
US$ 2,850.00
2015 Global In-vitro Colorectal Cancer Screening Tests Industry Report is a professional and in-depth research report on the world's major regional market conditions of the In-vitro Colorectal Cancer Screening Tests industry ... : 1.) basic information; 2.) the Asia In-vitro Colorectal Cancer Screening Tests industry; 3.) the North American In-vitro Colorectal Cancer Screening Tests industry; 4.) the European In-vitro Colorectal Cancer Screening Tests industry; 5.) market entry and ...
March 2015
172 pages
Global Predictive Breast Cancer Gene Testing Industry 2015 Market Research Report
US$ 2,850.00
2015 Global Predictive Breast Cancer Gene Testing Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Predictive Breast Cancer Gene Testing industry ... : 1.) basic information; 2.) the Asia Predictive Breast Cancer Gene Testing industry; 3.) the North American Predictive Breast Cancer Gene Testing industry; 4.) the European Predictive Breast Cancer Gene Testing industry; 5.) market entry and ...
March 2015
172 pages
United States Breast Pumps Market Opportunities, 2011 - 2021
US$ 2,500.00
... competitive breast pumps market in the United States. “United States Breast Pumps Market Opportunities, 2011 - 2021” report elaborates the following aspects of breast pumps market in the United States: United States Breast Pumps Market Size, Share & Forecast Segmental Analysis – By Type (Manual Breast Pumps ...
March 2015
90 pages
United States Cancer Biomarker Market Opportunities, 2011 - 2021
US$ 2,500.00
... their market position in a highly competitive cancer biomarker market in the United States. “United States Cancer Biomarker Market Opportunities, 2011 - 2021” report elaborates the following aspects of cancer biomarker market in the United States: United States Cancer Biomarker Market Size, Share ...
March 2015
117 pages
Europe Non-Small Cell Lung Cancer Treatments Market Opportunities, 2010 - 2020
US$ 3,000.00
... a highly competitive non-small cell lung cancer treatments market in Europe. “Europe Non-Small Cell Lung Cancer Treatments Market Opportunities, 2010 - 2020” report elaborates the following aspects of non-small cell lung cancer treatments market in Europe: Europe Non-Small Cell Lung Cancer Treatments Market ...
February 2015
122 pages
United States Breast Cancer Diagnostic Devices Market Opportunities, 2010 - 2020
US$ 2,500.00
... competitive breast cancer diagnostic devices market in the United States. “United States Breast Cancer Diagnostic Devices Market Opportunities, 2010 - 2020” report elaborates the following aspects of breast cancer diagnostic devices market in the United States: United States Breast Cancer Diagnostics Market ...
February 2015
108 pages
Cancer Nanomedicine Market & Pipeline Insight 2015
US$ 2,000.00
... cancer therapy can be achieved. “Cancer Nanomedicine Market & Pipeline Insight 2015” Report Highlight Nanomedicine for Cancer Therapies Cancer Nanoparticles Drug Delivery Systems Classification Mechanism of Cancer Nanomedicine Therapy Cancer Nanomedicine Clinical Pipeline Overview Cancer Nanomedicine ...
February 2015
220 pages
2015 Analysis of Cancer Diagnostic Technologies, and Strategic Profiles of Leading Suppliers
US$ 2,800.00
... assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, ...
January 2015
185 pages
2015 European Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK
US$ 15,760.00
... during the next five years. The report examines trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging ... basis of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field ...
January 2015
820 pages
2015 Global Cancer Diagnostics Market: Toward a New Future for Tumor Markers R&D Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Country Segment Forecasts, Supplier Shares, Innovative Technologies, Competitive Strategies
US$ 27,800.00
... -tailored to your specific information needs and budget. “2015 Global Cancer Diagnostics Market: Toward a New Future for Tumor Markers R&D Oncogenes, ... Asia; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and ...
January 2015
1200 pages
2015 Emerging Cancer Diagnostic Tests and Companies Developing New Technologies
US$ 2,280.00
... Factors, Lymphokines, Immunohistochemical Stains and others. The report presents an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing or ...
January 2015
260 pages
Dendritic Cell Cancer Vaccine Market & Clinical Insight
US$ 1,800.00
... Dendritic Cell Cancer Vaccines Dendritic Cell Vaccine Market Overview Market Dynamics (Drivers, Challenges & Future Prospects) Clinical Pipeline Insight by Phase, Indication & Company Dendritic Cell Cancer Vaccine in Clinical Pipeline: 52 Majority of Dendritic Cell Cancer Vaccine ...
January 2015
190 pages
Global Non Small Cell Lung Cancer Market & Pipeline Insight
US$ 2,400.00
... Non Small Cell Lung Cancer Market & Pipeline Insight” Report Highlights: NSCLC Therapy Market Overview Mechanism of NSCLC Therapeutics NSCLC Therapy Market Dynamics: Drivers, Challenges & Future Prospects) NSCLC Drug Pipeline ...
January 2015
750 pages
Global Prostate Cancer Vaccine Clinical Pipeline Insight 2015
US$ 1,500.00
... body to activate the immune cells. They identify these antigens as non-self and begin to search and eliminate cancerous cells from body ... ” Report Highlights: Introduction to Prostate Cancer Vaccine Mechanism of Prostate Cancer Vaccine Global Prostate Cancer Vaccine Clinical Trial Insight by Company, Country ...
January 2015
155 pages
Small Molecule Cancer Drug Clinical Pipeline Insight
US$ 2,400.00
... the treatment of Non-Small Cell Lung Cancer (NSCLC), Colon cancer, Breast and other cancers. Development of small molecule cancer drug generally ... Insight” Report Findings: Role of Small Molecule Drug in Cancer Treatment Mechanism of Small Molecule Cancer Drug Small Molecule Cancer Drugs Market Dynamics ...
January 2015
1650 pages
Competitor Analysis: Cancer Peptides
US$ 500.00
Competitor Analysis: Cancer Peptides The Competitive Intelligence Report Cancer Peptides as of November 2014 provides a competitor analysis in the product portfolios and development pipeline of peptide therapeutics for treatment of cancer. Purchase of the pdf report includes a 6-month online access to the ...
November 2014
99 pages
